Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-09-01 Sale |
2021-09-03 4:54 pm |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
112,411 | $8.3946 | $943,646 | 5,822,554 (Indirect Direct) |
View |
| 2021-08-20 Sale |
2021-08-24 5:12 pm |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
4,000 | $8.7854 | $35,142 | 132,346 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 4:57 pm |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
33,673 | $8.0471 | $270,970 | 5,765,167 (Indirect Direct) |
View |
| 2021-07-01 Sale |
2021-07-06 5:35 pm |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
48,105 | $9.275 | $446,174 | 5,781,272 (Indirect Direct) |
View |
| 2021-06-11 Sale |
2021-06-14 6:18 pm |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
4,000 | $9.4368 | $37,747 | 136,346 (Direct) |
View |
| 2021-06-01 Sale |
2021-06-03 7:21 pm |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
81,916 | $8.4758 | $694,302 | 5,804,278 (Indirect Direct) |
View |
| 2021-05-03 Sale |
2021-05-05 7:29 pm |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
54,312 | $8.6323 | $468,839 | 5,843,455 (Indirect Direct) |
View |
| 2021-04-21 Sale |
2021-04-23 8:49 pm |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
4,000 | $8.438 | $33,752 | 269,207 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-05 7:50 pm |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
115,000 | $9.6087 | $1,104,998 | 5,866,944 (Indirect Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 7:38 pm |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
115,000 | $11.6 | $1,334,461 | 5,924,431 (Indirect Direct) |
View |
| 2021-02-16 Sale |
2021-02-17 5:28 pm |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
133,149 | $10 | $1,332,036 | 9,840,253 (Indirect Direct) |
View |
| 2021-02-10 Sale |
2021-02-12 5:03 pm |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
12,389 | $10 | $123,890 | 9,973,402 (Indirect Direct) |
View |
| 2021-01-21 Sale |
2021-01-25 7:42 pm |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
4,462 | $10 | $44,620 | 9,918,257 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-08-25 Option Award |
2021-08-27 5:08 pm |
N/A 2031-08-24 |
Poseida Therapeutics Inc. | PSTX | Corning Luke Director |
45,833 | $0 | 45,833 (Direct) |
View |
| 2021-08-20 Exercise |
2021-08-24 5:12 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
4,000 | $1.322 | 132,346 (Direct) |
View |
| 2021-08-20 Exercise |
2021-08-24 5:12 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
4,000 | $0 | 132,346 (Direct) |
View |
| 2021-08-06 Exercise |
2021-08-10 6:56 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
111,149 | $9.15 | 10,392,835 (Direct) |
View |
| 2021-08-06 Exercise |
2021-08-10 6:56 pm |
N/A 2031-02-03 |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
111,149 | $0 | 10,392,835 (Direct) |
View |
| 2021-07-28 Exercise |
2021-07-30 4:29 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
20,000 | $1.322 | 136,346 (Direct) |
View |
| 2021-07-28 Exercise |
2021-07-30 4:29 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
20,000 | $0 | 136,346 (Direct) |
View |
| 2021-07-23 Option Award |
2021-07-26 8:32 pm |
N/A 2031-07-23 |
Poseida Therapeutics Inc. | PSTX | Schmid John P. Director |
25,833 | $0 | 25,833 (Direct) |
View |
| 2021-07-23 Option Award |
2021-07-26 8:31 pm |
N/A 2031-07-23 |
Poseida Therapeutics Inc. | PSTX | Lloyd Marcea Bland Director |
25,833 | $0 | 25,833 (Direct) |
View |
| 2021-07-23 Option Award |
2021-07-26 8:30 pm |
N/A 2031-07-23 |
Poseida Therapeutics Inc. | PSTX | Hirsch David Director |
25,833 | $0 | 25,833 (Direct) |
View |
| 2021-07-23 Option Award |
2021-07-26 8:29 pm |
N/A 2031-07-23 |
Poseida Therapeutics Inc. | PSTX | Collins Cynthia Director |
87,440 | $0 | 87,440 (Direct) |
View |
| 2021-06-17 Exercise |
2021-06-21 8:02 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
5,000 | $1.322 | 136,346 (Direct) |
View |
| 2021-06-17 Exercise |
2021-06-21 8:02 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
5,000 | $0 | 136,346 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 5:03 pm |
N/A 2031-06-15 |
Poseida Therapeutics Inc. | PSTX | Lloyd Marcea Bland Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 5:03 pm |
N/A 2031-06-15 |
Poseida Therapeutics Inc. | PSTX | Schmid John P. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 5:03 pm |
N/A 2031-06-15 |
Poseida Therapeutics Inc. | PSTX | Hirsch David Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-11 Exercise |
2021-06-14 6:18 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
4,000 | $1.322 | 136,346 (Direct) |
View |
| 2021-06-11 Exercise |
2021-06-14 6:18 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
4,000 | $0 | 136,346 (Direct) |
View |
Ownership(A) |
2021-05-05 7:27 pm |
N/A 2021-02-28 |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
0 | $0 | 99,610 (Direct) |
View |
| 2021-04-21 Exercise |
2021-04-23 8:49 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
9,000 | $1.322 | 269,207 (Direct) |
View |
| 2021-04-21 Exercise |
2021-04-23 8:49 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
9,000 | $0 | 269,207 (Direct) |
View |
| 2021-02-23 Exercise |
2021-02-25 7:01 pm |
N/A 2026-02-28 |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
111,395 | $0 | 9,954,405 (Direct) |
View |
| 2021-02-23 Exercise |
2021-02-25 7:01 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
111,395 | $1.173 | 9,954,405 (Direct) |
View |
| 2021-02-10 Exercise |
2021-02-12 5:03 pm |
N/A 2026-02-28 |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
67,534 | $0 | 9,973,402 (Direct) |
View |
| 2021-02-10 Exercise |
2021-02-12 5:03 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
67,534 | $1.29 | 9,973,402 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-05 4:54 pm |
N/A 2031-02-03 |
Poseida Therapeutics Inc. | PSTX | Mylet Johanna Senior Vice President, Finance |
82,000 | $0 | 82,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-05 4:54 pm |
N/A 2031-02-03 |
Poseida Therapeutics Inc. | PSTX | LEONHARDT HARRY J GC & Chief Compliance Officer |
137,000 | $0 | 137,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-05 4:53 pm |
N/A 2031-02-03 |
Poseida Therapeutics Inc. | PSTX | Ingalls Kerry D. Chief Operating Officer |
137,000 | $0 | 137,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-05 4:52 pm |
N/A 2031-02-03 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
164,000 | $0 | 164,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-05 4:52 pm |
N/A 2031-02-03 |
Poseida Therapeutics Inc. | PSTX | Gergen Mark J President and CBO |
342,000 | $0 | 342,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-05 4:51 pm |
N/A 2031-02-03 |
Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner |
889,193 | $0 | 889,193 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-19 5:00 pm |
N/A 2025-06-18 |
Poseida Therapeutics Inc. | PSTX | Mylet Johanna Senior Vice President, Finance |
4,728 | $0 | 26,813 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-19 5:00 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Mylet Johanna Senior Vice President, Finance |
4,728 | $0.3 | 26,813 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-19 5:00 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
7,564 | $1.322 | 144,346 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-19 5:00 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
7,564 | $0 | 144,346 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-11 5:00 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
3,921 | $1.322 | 144,346 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-11 5:00 pm |
N/A 2026-06-19 |
Poseida Therapeutics Inc. | PSTX | Spear Matthew A. Chief Medical Officer |
3,921 | $0 | 144,346 (Direct) |
View |
Ownership |
2020-12-28 4:06 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Corning Luke Director |
0 | $0 | 4,967,227 (Indirect) |
View |
Ownership |
2020-09-22 7:37 pm |
N/A 2030-07-08 |
Poseida Therapeutics Inc. | PSTX | LEONHARDT HARRY J GC & Chief Compliance Officer |
0 | $0 | 160,385 (Direct) |
View |
| 2020-07-14 Conversion |
2020-07-16 4:53 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | NOVARTIS PHARMA AG NOVARTIS AG 10% Owner |
13,275,476 | $0 | 5,908,089 (Direct) |
View |
| 2020-07-14 Conversion |
2020-07-15 5:00 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd Malin Corp plc 10% Owner |
20,645,718 | $0 | 9,188,125 (Direct) |
View |